This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Unigene Laboratories, Inc.
Drug Names(s): UGP281
Description: UGP281 is a potent anorexigenic peptide selectively targeting the amylin receptor designed to diminish or control appetite and weightloss in morbidly obese patients.
Additional information available to subscribers only: